ES2071038T3 - Peptidos asociados al hiv. - Google Patents
Peptidos asociados al hiv.Info
- Publication number
- ES2071038T3 ES2071038T3 ES90311056T ES90311056T ES2071038T3 ES 2071038 T3 ES2071038 T3 ES 2071038T3 ES 90311056 T ES90311056 T ES 90311056T ES 90311056 T ES90311056 T ES 90311056T ES 2071038 T3 ES2071038 T3 ES 2071038T3
- Authority
- ES
- Spain
- Prior art keywords
- leu
- lys
- glu
- ala
- ser
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 abstract 1
- 102000007079 Peptide Fragments Human genes 0.000 abstract 1
- 108010033276 Peptide Fragments Proteins 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
LOS FRAGMENTOS DE PROTEINA P17 DEL HIV QUE VARIAN EN LONGITUD DESDE UNOS 12 A UNOS 14 AMINOACIDOS SE UTILIZAN PARA FORMAR DIAGNOSTICOS Y VACUNAS PARA LA DETECCION Y TRATAMIENTO DEL SIDA. FRAGMENTOS PEPTIDOS ESPECIFICOS SE EXTIENDEN DESDE EL TERMINAL N HASTA EL TERMINAL C. LOS PEPTIDOS QUE TIENEN LAS SECUENCIAS DE AMINOACIDOS QUE SE MUESTRAN EN LAS FORMULAS (I), (II), (III), (IV) Y (V) SIGUIENTES: TYR-SER-VAL-HIS-GLN-ARG-LLE-ASP-VAL-LYS-ASP-THR-LYS-GLU-ALA-LEU-GLY-LYS-LLE -GLU-GLU-GLU-GLN-ASN-LYS-SER-LYS-LYS-LYS-ALA GLY-ALA-ARG-ALA-SER-VAL-LEU-SER-GLY-GLY-GLU-LEU-ASP-ARG-TRP-GLU-LYS-LLE-ARG -LEU-ARG-PRO-GLY-GLY-LYS-LYS-LYS-TYR-LYS-LEU-LYS-HIS LLE-VAL-TRP-ALA-SER-ARG-GLU-LEU-GLU-ARG-PHE-ALA-VAL-ASN-PRO-GLY-LEU-LEU GLU-THR-SER-GLU-GLY-CYS-ARG-GLN-LLE-LEU-GLY-GLN-LEU-GLN-PRO-SER-LEU-GLN-THR -GLY-SER-GLU-GLU-LEU-ARG-SER-LEU-TYR-ASN-THR-VAL-ALA-THR-LEU ALA-GLN-GLN-ALA-ALA-ALA-ASP-THR-GLY-HIS-SER-SER-GLN-VAL-SER-GLN-ASN-TYR SON INMUNOREACTIVOS A ANTICUERPOS EN LOS PACIENTES QUE SON SEROPOSITIVOS ALA P17 DEL HIV-1.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42046989A | 1989-10-12 | 1989-10-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2071038T3 true ES2071038T3 (es) | 1995-06-16 |
Family
ID=23666609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90311056T Expired - Lifetime ES2071038T3 (es) | 1989-10-12 | 1990-10-09 | Peptidos asociados al hiv. |
Country Status (17)
Country | Link |
---|---|
EP (3) | EP0426314B1 (es) |
JP (1) | JPH03209398A (es) |
KR (1) | KR910007962A (es) |
CN (1) | CN1052310A (es) |
AT (1) | ATE119166T1 (es) |
AU (1) | AU6393990A (es) |
CA (1) | CA2027455A1 (es) |
DE (1) | DE69017352T2 (es) |
DK (1) | DK0426314T3 (es) |
ES (1) | ES2071038T3 (es) |
GB (1) | GB2236754A (es) |
GR (1) | GR3015244T3 (es) |
HU (1) | HUT55035A (es) |
IE (1) | IE67533B1 (es) |
IL (1) | IL95890A0 (es) |
NZ (1) | NZ235538A (es) |
ZA (1) | ZA907944B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4039925A1 (de) * | 1990-12-14 | 1992-06-17 | Behringwerke Ag | Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung |
FR2734281B1 (fr) * | 1995-05-18 | 1997-07-25 | Commissariat Energie Atomique | Fragments d'acide nucleique derives du genome du virus vih-1, peptides correspondants et leurs applications en tant que reactifs d'evaluation du risque de transmission materno-foetale du vih-1 |
US6103239A (en) * | 1996-08-09 | 2000-08-15 | Cel-Sci Corporation | Modified HGP-30 heteroconjugates, compositions and methods of use |
NO314588B1 (no) * | 2000-09-04 | 2003-04-14 | Bionor Immuno As | HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV |
ATE478089T1 (de) * | 2001-08-07 | 2010-09-15 | Medestea Int Spa | Isolierte polypeptide auf der grundlage des neutralisierenden epitops des p17-proteins vom hiv geeignet als impfstoffe und neutralisierende anti-p17-antikörper, die besagtes epitop spezifisch erkennen |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0230222A1 (en) * | 1986-01-06 | 1987-07-29 | F. Hoffmann-La Roche Ag | Expression of HTLV-III gag-Gene |
NZ220200A (en) * | 1986-05-19 | 1990-08-28 | Viral Technologies Inc | Hiv related peptides, antibodies to the peptides and vaccines therefrom |
JPH0762031B2 (ja) * | 1986-12-30 | 1995-07-05 | アメリカ合衆国 | エイズウイルスおよびエイズウイルスのタンパク質に対する細胞性免疫を誘導する合成ペプチド |
NO881151L (no) * | 1987-03-27 | 1988-09-28 | Syntello Ab | Syntetisk hiv-1-antigen. |
DK643188A (da) * | 1987-11-24 | 1989-05-25 | Smithkline Biolog | Ekspression af hiv-proteiner i e.coli og s.cerevisiae |
EP0330359A3 (en) * | 1988-02-25 | 1991-06-05 | Bio-Rad Laboratories, Inc. | Composition useful in the diagnosis and treating of hiv-1 infection |
-
1990
- 1990-10-02 NZ NZ235538A patent/NZ235538A/en unknown
- 1990-10-03 IL IL95890A patent/IL95890A0/xx unknown
- 1990-10-04 ZA ZA907944A patent/ZA907944B/xx unknown
- 1990-10-09 EP EP90311056A patent/EP0426314B1/en not_active Revoked
- 1990-10-09 GB GB9021942A patent/GB2236754A/en not_active Withdrawn
- 1990-10-09 EP EP94106294A patent/EP0620010A1/en not_active Withdrawn
- 1990-10-09 AT AT90311056T patent/ATE119166T1/de not_active IP Right Cessation
- 1990-10-09 ES ES90311056T patent/ES2071038T3/es not_active Expired - Lifetime
- 1990-10-09 IE IE360490A patent/IE67533B1/en not_active IP Right Cessation
- 1990-10-09 EP EP94106293A patent/EP0620009A1/en not_active Withdrawn
- 1990-10-09 DE DE69017352T patent/DE69017352T2/de not_active Revoked
- 1990-10-09 DK DK90311056.7T patent/DK0426314T3/da active
- 1990-10-10 AU AU63939/90A patent/AU6393990A/en not_active Abandoned
- 1990-10-11 JP JP2273128A patent/JPH03209398A/ja active Pending
- 1990-10-11 HU HU906421A patent/HUT55035A/hu unknown
- 1990-10-12 CA CA002027455A patent/CA2027455A1/en not_active Abandoned
- 1990-10-12 KR KR1019900016184A patent/KR910007962A/ko not_active Application Discontinuation
- 1990-10-12 CN CN90108411A patent/CN1052310A/zh active Pending
-
1995
- 1995-03-02 GR GR940403828T patent/GR3015244T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU6393990A (en) | 1991-04-18 |
HU906421D0 (en) | 1991-04-29 |
HUT55035A (en) | 1991-04-29 |
CA2027455A1 (en) | 1991-04-13 |
DE69017352T2 (de) | 1995-10-05 |
JPH03209398A (ja) | 1991-09-12 |
EP0426314B1 (en) | 1995-03-01 |
CN1052310A (zh) | 1991-06-19 |
IE903604A1 (en) | 1991-04-24 |
GB2236754A (en) | 1991-04-17 |
EP0620009A1 (en) | 1994-10-19 |
IL95890A0 (en) | 1991-07-18 |
ATE119166T1 (de) | 1995-03-15 |
KR910007962A (ko) | 1991-05-30 |
DE69017352D1 (de) | 1995-04-06 |
NZ235538A (en) | 1992-06-25 |
IE67533B1 (en) | 1996-04-03 |
EP0620010A1 (en) | 1994-10-19 |
EP0426314A3 (en) | 1991-07-24 |
GR3015244T3 (en) | 1995-06-30 |
ZA907944B (en) | 1991-10-30 |
EP0426314A2 (en) | 1991-05-08 |
DK0426314T3 (da) | 1995-03-27 |
GB9021942D0 (en) | 1990-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR247590A1 (es) | Una secuencia de adn que codifica derivados de factor viii humano recombinante y un procedimiento para su obtencion | |
DE3588254D1 (de) | Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen | |
HUP0100928A2 (hu) | Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
NL300013I1 (nl) | Nieuwe protein met TNF-remmende werking en hun ber | |
NO891711L (no) | Hiv env-kodet peptid som er istand til aa fremkalle hiv-inhiberende antistoffer i pattedyr. | |
GB2255093A (en) | Hiv-1 core protein fragments | |
CY1110927T1 (el) | Αμινο-καταληκτικως διακλαδισμενη rantεs ως ανταγωνιστης των χημοκινων | |
ATE134195T1 (de) | Peptidfragmente von hiv | |
FR2670787B1 (fr) | Lipopeptides inducteurs des lymphocytes t cytotoxiques et utilisation comme vaccins. | |
ES2071038T3 (es) | Peptidos asociados al hiv. | |
DE69007571D1 (de) | Peptidfragmente von HIV. | |
DE69508382D1 (de) | Peptomere mit erhöhter immunogenizität | |
ES2095899T3 (es) | Peptidos de la proteina gag de vih, su preparacion y uso. | |
DE69330348D1 (de) | Verwendung von Peptiden welche eine Immunantwort bewirken zur Herstellung von Medikamenten zur Induzierung der Immunsuppression. | |
PT87239A (pt) | Process for the preparation of peptides | |
YU64192A (sh) | Analozi insulina | |
DE69012989D1 (de) | Peptiden von retinblastoma gen produkten und antikoerper dagegen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 426314 Country of ref document: ES |